The University of Southampton
University of Southampton Institutional Repository

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease
Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease
Objective: Altered microbiota composition, changes in immune responses and impaired intestinal barrier functions are observed in IBD. Most of these features are controlled by proteases and their inhibitors to maintain gut homeostasis. Unrestrained or excessive proteolysis can lead to pathological gastrointestinal conditions. The aim was to validate the identified protease IBD candidates from a previously performed systematic review through a genetic association study and functional follow-up.

Design: We performed a genetic association study in a large multicentre cohort of patients with Crohn's disease (CD) and UC from five European IBD referral centres in a total of 2320 CD patients, 2112 UC patients and 1796 healthy controls. Subsequently, we did an extensive functional assessment of the candidate genes to explore their causality in IBD pathogenesis.

Results: Ten single nucleotide polymorphisms (SNPs) in four genes were significantly associated with CD: CYLD, USP40, APEH and USP3. CYLD was the most significant gene with the intronically located rs12324931 the strongest associated SNP (pFDR=1.74e-17, OR=2.24 (1.83 to 2.74)). Five SNPs in four genes were significantly associated with UC: USP40, APEH, DAG1 and USP3. CYLD, as well as some of the other associated genes, is part of the ubiquitin proteasome system (UPS). We therefore determined if the IBD-associated adherent-invasive Escherichia coli (AIEC) can modulate the UPS functioning. Infection of intestinal epithelial cells with the AIEC LF82 reference strain modulated the UPS turnover by reducing poly-ubiquitin conjugate accumulation, increasing 26S proteasome activities and decreasing protein levels of the NF-?B regulator CYLD. This resulted in I?B-? degradation and NF-?B activation. This activity was very important for the pathogenicity of AIEC since decreased CYLD resulted in increased ability of AIEC LF82 to replicate intracellularly.

Conclusions: Our results reveal the UPS, and CYLD specifically, as an important contributor to IBD pathogenesis, which is favoured by both genetic and microbial factors.
0017-5749
1265-1274
Cleynen, I.
8cc0a74f-5f08-469b-9f07-739a1d4ffa18
Vazeille, E.
cc9804ae-9dad-42f0-a2ea-dc3e5f560390
Artieda, M.
d38a6149-cac7-40ba-9bbc-e3316ba58399
Verspaget, H.W.
ad37f6cf-49de-4289-aaae-d297fec08230
Szczypiorska, M.
c8a3acc7-a80d-43ee-8a4e-6cd4f549bf1c
Bringer, M.A.
92d3d45d-b43f-4c46-99f8-2241419cdb8a
Lakatos, P.L.
e082a82b-c6e5-4199-8176-96505933642f
Seibold, F.
aacfd934-d751-447b-8de7-156a40535753
Parnell, K.
5d563f38-b0a2-4703-8adb-00819611448c
Weersma, R.K.
3bcc0fa3-2db6-4861-8325-b8e2a8626e5a
Mahachie, John J.M.
27b70a52-4500-46ac-9243-457085bb2fbc
Morgan-Walsh, R.
5da9c5fd-fab8-4769-af6e-bf248980f558
Staelens, D.
8dcefb1b-43c8-4ffb-9bbc-d1a9cf8523bf
Arijs, I.
712ea688-0671-4f0e-af3e-e14711a99e07
De Hertogh, G.
a99143b5-fbd5-48bb-a7a2-97af4023d31f
Muller, S
4e3e8a13-57d3-48d1-ac76-468e8455ef2a
Tordai, A
b5bc2ee6-8398-4bb5-85fd-755cd018b9ea
Hommes, D.W.
3bf1b1c0-327b-4acb-89d5-16dcfca38a1f
Ahmad, T.
e08bd998-6015-4b52-9b8e-55ef435e6bf9
Wijmenga, C.
4b2aa371-0ea3-432b-bb4b-4a32fcc70447
Pender, S.L.
62528b03-ec42-41bb-80fe-48454c2c5242
Rutgeerts, P.
15660f34-8e7b-486f-a07b-15cccd38be85
Van Steen, K.
f62c8e07-42b0-45b4-933a-05cc55e231c8
Lottaz, D.
f5e76647-6db5-4fc8-a813-e50e47f88ff8
Vermeire, S.
0b6fc72b-e4b0-4089-a852-0f314ee0161b
Darfeuille-Michaud, A.
58a8bfe5-7939-4aaa-8871-6514eaf76da4
Cleynen, I.
8cc0a74f-5f08-469b-9f07-739a1d4ffa18
Vazeille, E.
cc9804ae-9dad-42f0-a2ea-dc3e5f560390
Artieda, M.
d38a6149-cac7-40ba-9bbc-e3316ba58399
Verspaget, H.W.
ad37f6cf-49de-4289-aaae-d297fec08230
Szczypiorska, M.
c8a3acc7-a80d-43ee-8a4e-6cd4f549bf1c
Bringer, M.A.
92d3d45d-b43f-4c46-99f8-2241419cdb8a
Lakatos, P.L.
e082a82b-c6e5-4199-8176-96505933642f
Seibold, F.
aacfd934-d751-447b-8de7-156a40535753
Parnell, K.
5d563f38-b0a2-4703-8adb-00819611448c
Weersma, R.K.
3bcc0fa3-2db6-4861-8325-b8e2a8626e5a
Mahachie, John J.M.
27b70a52-4500-46ac-9243-457085bb2fbc
Morgan-Walsh, R.
5da9c5fd-fab8-4769-af6e-bf248980f558
Staelens, D.
8dcefb1b-43c8-4ffb-9bbc-d1a9cf8523bf
Arijs, I.
712ea688-0671-4f0e-af3e-e14711a99e07
De Hertogh, G.
a99143b5-fbd5-48bb-a7a2-97af4023d31f
Muller, S
4e3e8a13-57d3-48d1-ac76-468e8455ef2a
Tordai, A
b5bc2ee6-8398-4bb5-85fd-755cd018b9ea
Hommes, D.W.
3bf1b1c0-327b-4acb-89d5-16dcfca38a1f
Ahmad, T.
e08bd998-6015-4b52-9b8e-55ef435e6bf9
Wijmenga, C.
4b2aa371-0ea3-432b-bb4b-4a32fcc70447
Pender, S.L.
62528b03-ec42-41bb-80fe-48454c2c5242
Rutgeerts, P.
15660f34-8e7b-486f-a07b-15cccd38be85
Van Steen, K.
f62c8e07-42b0-45b4-933a-05cc55e231c8
Lottaz, D.
f5e76647-6db5-4fc8-a813-e50e47f88ff8
Vermeire, S.
0b6fc72b-e4b0-4089-a852-0f314ee0161b
Darfeuille-Michaud, A.
58a8bfe5-7939-4aaa-8871-6514eaf76da4

Cleynen, I., Vazeille, E., Artieda, M., Verspaget, H.W., Szczypiorska, M., Bringer, M.A., Lakatos, P.L., Seibold, F., Parnell, K., Weersma, R.K., Mahachie, John J.M., Morgan-Walsh, R., Staelens, D., Arijs, I., De Hertogh, G., Muller, S, Tordai, A, Hommes, D.W., Ahmad, T., Wijmenga, C., Pender, S.L., Rutgeerts, P., Van Steen, K., Lottaz, D., Vermeire, S. and Darfeuille-Michaud, A. (2014) Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut, 63 (8), 1265-1274. (doi:10.1136/gutjnl-2012-303205). (PMID:24092863)

Record type: Article

Abstract

Objective: Altered microbiota composition, changes in immune responses and impaired intestinal barrier functions are observed in IBD. Most of these features are controlled by proteases and their inhibitors to maintain gut homeostasis. Unrestrained or excessive proteolysis can lead to pathological gastrointestinal conditions. The aim was to validate the identified protease IBD candidates from a previously performed systematic review through a genetic association study and functional follow-up.

Design: We performed a genetic association study in a large multicentre cohort of patients with Crohn's disease (CD) and UC from five European IBD referral centres in a total of 2320 CD patients, 2112 UC patients and 1796 healthy controls. Subsequently, we did an extensive functional assessment of the candidate genes to explore their causality in IBD pathogenesis.

Results: Ten single nucleotide polymorphisms (SNPs) in four genes were significantly associated with CD: CYLD, USP40, APEH and USP3. CYLD was the most significant gene with the intronically located rs12324931 the strongest associated SNP (pFDR=1.74e-17, OR=2.24 (1.83 to 2.74)). Five SNPs in four genes were significantly associated with UC: USP40, APEH, DAG1 and USP3. CYLD, as well as some of the other associated genes, is part of the ubiquitin proteasome system (UPS). We therefore determined if the IBD-associated adherent-invasive Escherichia coli (AIEC) can modulate the UPS functioning. Infection of intestinal epithelial cells with the AIEC LF82 reference strain modulated the UPS turnover by reducing poly-ubiquitin conjugate accumulation, increasing 26S proteasome activities and decreasing protein levels of the NF-?B regulator CYLD. This resulted in I?B-? degradation and NF-?B activation. This activity was very important for the pathogenicity of AIEC since decreased CYLD resulted in increased ability of AIEC LF82 to replicate intracellularly.

Conclusions: Our results reveal the UPS, and CYLD specifically, as an important contributor to IBD pathogenesis, which is favoured by both genetic and microbial factors.

This record has no associated files available for download.

More information

Accepted/In Press date: 23 August 2013
e-pub ahead of print date: 3 October 2013
Published date: 8 July 2014
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 359251
URI: http://eprints.soton.ac.uk/id/eprint/359251
ISSN: 0017-5749
PURE UUID: 1b4b304d-14ef-4dcc-bb3b-0186cddb5816
ORCID for S.L. Pender: ORCID iD orcid.org/0000-0001-6332-0333

Catalogue record

Date deposited: 24 Oct 2013 12:53
Last modified: 15 Mar 2024 03:08

Export record

Altmetrics

Contributors

Author: I. Cleynen
Author: E. Vazeille
Author: M. Artieda
Author: H.W. Verspaget
Author: M. Szczypiorska
Author: M.A. Bringer
Author: P.L. Lakatos
Author: F. Seibold
Author: K. Parnell
Author: R.K. Weersma
Author: John J.M. Mahachie
Author: R. Morgan-Walsh
Author: D. Staelens
Author: I. Arijs
Author: G. De Hertogh
Author: S Muller
Author: A Tordai
Author: D.W. Hommes
Author: T. Ahmad
Author: C. Wijmenga
Author: S.L. Pender ORCID iD
Author: P. Rutgeerts
Author: K. Van Steen
Author: D. Lottaz
Author: S. Vermeire
Author: A. Darfeuille-Michaud

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×